| 000 | 01686 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517074616.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkv457 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aValour, Florent | |
| 245 | 0 | 0 |
_aPristinamycin in the treatment of MSSA bone and joint infection. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cApr 2016 |
||
| 300 |
_a1063-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Infectious _xdrug therapy |
| 650 | 0 | 4 |
_aBone Diseases, Infectious _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPristinamycin _xpharmacology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBoibieux, André | |
| 700 | 1 | _aKarsenty, Judith | |
| 700 | 1 | _aVallat, Marie-Paule | |
| 700 | 1 | _aBraun, Evelyne | |
| 700 | 1 | _aPerpoint, Thomas | |
| 700 | 1 | _aBiron, François | |
| 700 | 1 | _aLaurent, Frédéric | |
| 700 | 1 | _aLustig, Sébastien | |
| 700 | 1 | _aChidiac, Christian | |
| 700 | 1 | _aFerry, Tristan | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 71 _gno. 4 _gp. 1063-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkv457 _zAvailable from publisher's website |
| 999 |
_c25660791 _d25660791 |
||